Test system for the detection of binding antibodies to interferon beta-1a for clinical use

Test system for the detection of binding antibodies to interferon beta-1a for clinical use

Test system for determining the presence of binding antibodies to interferon beta-1a (BAB to IFN beta-1a) in serum using ELISA has been developed. The validation included sensitivity, selectivity, specificity, precision and accuracy, robustness, stability, suitability of the test system studies. The...

Full description

Saved in:
Bibliographic Details
Main Authors: E. A. Kuzminova, T. Yu. Ostroukhova, A. V. Grachev, E. L. Morozova
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
интерферон бета 1а
иммуногенность
твердофазный иммуноферментный анализ (ифа)
связывающие антитела (сат)
антитела к препарату
рассеянный склероз
биоаналитические методы исследования
клинические исследования
interferon beta-1a
immunogenicity
enzyme linked immunosorbent assay (elisa)
binding antibodies (bab)
anti-drug antibodies (adas)
multiple sclerosis (ms)
bioanalytical methods
clinical studies
Online Access:https://www.biopreparations.ru/jour/article/view/63
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Test system for determining the presence of binding antibodies to interferon beta-1a (BAB to IFN beta-1a) in serum using ELISA has been developed. The validation included sensitivity, selectivity, specificity, precision and accuracy, robustness, stability, suitability of the test system studies. The applicability of the mentioned test system has been approved for the use in clinical studies for the evaluation of interferon beta-1a immunogenicity (pegylated and non-pegylated forms).
ISSN:2221-996X
2619-1156

Similar Items